Treatment for chronic hives lasting at least 6 weeks may include one or more types of medication, as well as certain ...

France's Sanofi said its Dupixent drug jointly developed with Regeneron advanced toward a new indication for chronic hives in the European Union, while the U.S. Food and Drug Administration extended ...

There are many different types of hives -- urticaria -- with many different causes. In most cases, these puffy, red, or skin-colored bumps and wheals appear suddenly due to an allergic reaction to ...

If you're being treated for hives, your physician will want to hear what you think about your treatment. Is it working? Are your symptoms improving, staying the same, or getting worse? You may be ...

Hives, or urticaria, are a common skin rash that appears as raised, itchy welts. Sometimes, hives resolve quickly on their own, but if they persist, over-the-counter medications often help. Hives ...

Recommendation for adults and adolescents based on Phase 3 trials showing Dupixent significantly reduced itch and hives at 24 weeks compared to ...

Dupilumab has been evaluated in phase 3 clinical trials in patients with chronic spontaneous urticaria (CSU). What did the data show and what was the FDA’s response to the requested approval? There is ...

This informational guide, part of PS's Condition Center, lays out the realities of this health concern: what it is, what it can look like, and strategies that medical experts say are proven to help.

Please provide your email address to receive an email when new articles are posted on . Both guidelines begin with antihistamines. Guidelines in the US recommend further antihistamine use before ...